This site uses cookies. To learn more, please visit our Privacy Policy. By continuing to surf on our website, you consent to our use of cookies Close [X]
Perfusion Services Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Cardiopulmonary Bypass (CPB), Extracorporeal Membrane Oxygenation (ECMO), and Isolated Limb Perfusion); Application(Hospitals, Clinics, and Others) and Geography
| Report Code: TIPRE00025693 | No. of Pages: 150 | Category: Healthcare IT | Status: Upcoming
Market Insights
Perfusion Services Market 2028 By Type, Application and Geography | The Insight Partners
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
The component of a drug that produces the desired effects is known as the active pharmaceutical ingredient (API). Combination therapies, for example, in long term treatments have various active substances that cure different symptoms or act in different ways. API is the potent component in drug formulation and often used with additives or excipients to improve therapeutic efficacy of a medicine. Many pharmaceutial companies develop their API by own or by outsourcing operations. Some common examples of API are, diclofenac, propanolol, methotraxate etc.
MARKET SCOPE
The "Global Active Pharmaceutical Ingredient (API) Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the active pharmaceutical ingredient (API) market with detailed market segmentation by type of synthesis and therapeutic application. The report provides key statistics on the market status of the leading active pharmaceutical ingredient (API) market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
Based on type of synthesis the market is bifurcated as, biotech and synthetic.
Based on therapeutic application the market is segmented as, cardiology, oncology, CNS and neurology, orthopedic, endocrinology, pulmonology, gastroenterology, nephrology, ophthalmology and others.
MARKET DYNAMICS Drivers:
Significant growth in pharmaceutical & biotechnology companies.
Growth in R&D activities across the companies to develop novel molecules and APIs.
Increasing prevalnece of chronic diseases, idiosyncratic diseases and advancements in API production activities.
Restraints:
Issues such as higher manufacturing costs and time consuming method of API development.
Unfavorable DPCO guidelines are also expected to restrain market growth.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Active pharmaceutical ingredient (API) market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Active pharmaceutical ingredient (API) market in these regions.
IMPACT OF COVID-19 ON ACTIVE PHARMACEUTICAL INGREDIENT (API) MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. But some of the API molecules such as, remdesivir, favipiravir, and other such API have shown promising outcomes against covid-19 infection which has impacted positively on API market growth however, COVID-19 has disrupted all the business and economic activities across the globe which is expected to have some impact on active pharmaceutical ingredient (API) market. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
Get more information on this report :
MARKET PLAYERS
The report covers key developments in the Active pharmaceutical ingredient (API) market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Active pharmaceutical ingredient (API) market are anticipated to lucrative growth opportunities in the future with the rising demand for Active pharmaceutical ingredient (API) in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Active pharmaceutical ingredient (API) market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
Teva Pharmaceutical Industries Ltd.
AbbVie Inc.
Pfizer, Inc.
Cipla Inc.
Merck KGaA
Bristol Myers Squibb
GlaxoSmithKline plc
Mylan N.V.
Dr. Reddy's Laboratories Ltd
Sun Pharmaceutical Industries Ltd
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
Get more information on this report :
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Perfusion Services Market - By Type
1.3.2 Perfusion Services Market - By Application
1.3.3 Perfusion Services Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. PERFUSION SERVICES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. PERFUSION SERVICES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. PERFUSION SERVICES MARKET - GLOBAL MARKET ANALYSIS
6.1. PERFUSION SERVICES - GLOBAL MARKET OVERVIEW
6.2. PERFUSION SERVICES - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. PERFUSION SERVICES MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. CARDIOPULMONARY BYPASS (CPB)
7.3.1. Overview
7.3.2. Cardiopulmonary Bypass (CPB) Market Forecast and Analysis
7.4. EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO)
7.4.1. Overview
7.4.2. Extracorporeal Membrane Oxygenation (ECMO) Market Forecast and Analysis
7.5. ISOLATED LIMB PERFUSION
7.5.1. Overview
7.5.2. Isolated Limb Perfusion Market Forecast and Analysis
8. PERFUSION SERVICES MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. CLINICS
8.4.1. Overview
8.4.2. Clinics Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis
9. PERFUSION SERVICES MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Perfusion Services Market Overview
9.1.2 North America Perfusion Services Market Forecasts and Analysis
9.1.3 North America Perfusion Services Market Forecasts and Analysis - By Type
9.1.4 North America Perfusion Services Market Forecasts and Analysis - By Application
9.1.5 North America Perfusion Services Market Forecasts and Analysis - By Countries
9.1.5.1 United States Perfusion Services Market
9.1.5.1.1 United States Perfusion Services Market by Type
9.1.5.1.2 United States Perfusion Services Market by Application
9.1.5.2 Canada Perfusion Services Market
9.1.5.2.1 Canada Perfusion Services Market by Type
9.1.5.2.2 Canada Perfusion Services Market by Application
9.1.5.3 Mexico Perfusion Services Market
9.1.5.3.1 Mexico Perfusion Services Market by Type
9.1.5.3.2 Mexico Perfusion Services Market by Application
9.2. EUROPE
9.2.1 Europe Perfusion Services Market Overview
9.2.2 Europe Perfusion Services Market Forecasts and Analysis
9.2.3 Europe Perfusion Services Market Forecasts and Analysis - By Type
9.2.4 Europe Perfusion Services Market Forecasts and Analysis - By Application
9.2.5 Europe Perfusion Services Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Perfusion Services Market
9.2.5.1.1 Germany Perfusion Services Market by Type
9.2.5.1.2 Germany Perfusion Services Market by Application
9.2.5.2 France Perfusion Services Market
9.2.5.2.1 France Perfusion Services Market by Type
9.2.5.2.2 France Perfusion Services Market by Application
9.2.5.3 Italy Perfusion Services Market
9.2.5.3.1 Italy Perfusion Services Market by Type
9.2.5.3.2 Italy Perfusion Services Market by Application
9.2.5.4 Spain Perfusion Services Market
9.2.5.4.1 Spain Perfusion Services Market by Type
9.2.5.4.2 Spain Perfusion Services Market by Application
9.2.5.5 United Kingdom Perfusion Services Market
9.2.5.5.1 United Kingdom Perfusion Services Market by Type
9.2.5.5.2 United Kingdom Perfusion Services Market by Application
9.2.5.6 Rest of Europe Perfusion Services Market
9.2.5.6.1 Rest of Europe Perfusion Services Market by Type
9.2.5.6.2 Rest of Europe Perfusion Services Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Perfusion Services Market Overview
9.3.2 Asia-Pacific Perfusion Services Market Forecasts and Analysis
9.3.3 Asia-Pacific Perfusion Services Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Perfusion Services Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Perfusion Services Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Perfusion Services Market
9.3.5.1.1 Australia Perfusion Services Market by Type
9.3.5.1.2 Australia Perfusion Services Market by Application
9.3.5.2 China Perfusion Services Market
9.3.5.2.1 China Perfusion Services Market by Type
9.3.5.2.2 China Perfusion Services Market by Application
9.3.5.3 India Perfusion Services Market
9.3.5.3.1 India Perfusion Services Market by Type
9.3.5.3.2 India Perfusion Services Market by Application
9.3.5.4 Japan Perfusion Services Market
9.3.5.4.1 Japan Perfusion Services Market by Type
9.3.5.4.2 Japan Perfusion Services Market by Application
9.3.5.5 South Korea Perfusion Services Market
9.3.5.5.1 South Korea Perfusion Services Market by Type
9.3.5.5.2 South Korea Perfusion Services Market by Application
9.3.5.6 Rest of Asia-Pacific Perfusion Services Market
9.3.5.6.1 Rest of Asia-Pacific Perfusion Services Market by Type
9.3.5.6.2 Rest of Asia-Pacific Perfusion Services Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Perfusion Services Market Overview
9.4.2 Middle East and Africa Perfusion Services Market Forecasts and Analysis
9.4.3 Middle East and Africa Perfusion Services Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Perfusion Services Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Perfusion Services Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Perfusion Services Market
9.4.5.1.1 South Africa Perfusion Services Market by Type
9.4.5.1.2 South Africa Perfusion Services Market by Application
9.4.5.2 Saudi Arabia Perfusion Services Market
9.4.5.2.1 Saudi Arabia Perfusion Services Market by Type
9.4.5.2.2 Saudi Arabia Perfusion Services Market by Application
9.4.5.3 U.A.E Perfusion Services Market
9.4.5.3.1 U.A.E Perfusion Services Market by Type
9.4.5.3.2 U.A.E Perfusion Services Market by Application
9.4.5.4 Rest of Middle East and Africa Perfusion Services Market
9.4.5.4.1 Rest of Middle East and Africa Perfusion Services Market by Type
9.4.5.4.2 Rest of Middle East and Africa Perfusion Services Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Perfusion Services Market Overview
9.5.2 South and Central America Perfusion Services Market Forecasts and Analysis
9.5.3 South and Central America Perfusion Services Market Forecasts and Analysis - By Type
9.5.4 South and Central America Perfusion Services Market Forecasts and Analysis - By Application
9.5.5 South and Central America Perfusion Services Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Perfusion Services Market
9.5.5.1.1 Brazil Perfusion Services Market by Type
9.5.5.1.2 Brazil Perfusion Services Market by Application
9.5.5.2 Argentina Perfusion Services Market
9.5.5.2.1 Argentina Perfusion Services Market by Type
9.5.5.2.2 Argentina Perfusion Services Market by Application
9.5.5.3 Rest of South and Central America Perfusion Services Market
9.5.5.3.1 Rest of South and Central America Perfusion Services Market by Type
9.5.5.3.2 Rest of South and Central America Perfusion Services Market by Application
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL PERFUSION SERVICES MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. PERFUSION SERVICES MARKET, KEY COMPANY PROFILES
12.1. SPECIALTYCARE, INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. KEYSTONE PERFUSION
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. UPMC PROCIRCA
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. VIVACITY
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. PERFUSION SOLUTION, INC.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. CAMBRIDGE PERFUSION LLP
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. COMPREHENSIVE CARE
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. MYO PERFUSION GROUP LLC SERVICES, INC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. NEPA PERFUSION SERVICES, INC.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. CONNECTPERF.COM
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies
- SpecialtyCare, Inc.
- Keystone Perfusion
- UPMC Procirca
- VIVACITY
- Perfusion Solution, Inc.
- Cambridge Perfusion LLP
- Comprehensive Care Services, Inc.
- MYO Perfusion Group LLC
- NEPA Perfusion Services, Inc.
- ConnectPerf.com
